Indications for transplantation
Intestinal failure can be defined as an inability to maintain nutrition and/or positive intestinal fluid and electrolyte balance without special measures.' This may follow massive resection or may be caused by motility disorders or extensive disease inhibiting absorption. The commoner causes of irreversible intestinal failure include congenital atresias, gastroschisis, volvulus, and necrotising enterocolitis in neo- nates,2 volvulus, visceral myopathy, and mucosal abnormalities such as congenital enteropathies in older children, and Crohn's disease, resection for volvulus or desmoid tumours, and mesenteric infarction in adults. 3 In most cases of intestinal failure, especially those in infants, the residual intestine adapts, although it may take over two years to achieve resumption of a full enteral diet.3 Factors that mitigate against reversibility of intestinal failure are excessive loss of healthy bowel in relation to total length for age,2 absence of the ileocaecal valve and right colon,4 and poor function of the residual intestine.5 In some patients adaptation is insufficient to permit cessation of parenteral nutrition and intestinal failure is therefore permanent In most experimental and clinical cases of small bowel transplantation the graft has initially been placed out of continuity with the native intestine. This is to avoid anastomotic breakdown which would be a risk in the presence of ischaemia associated with early rejection. Therefore the ends of the graft are either both exteriorised as stomas,'3 14 or the proximal end is anastomosed to the native jejunum and the distal end brought out as a stoma.'5 16 This latter technique allows normal upper gastrointestinal secretions and enteral nutrition to flow through the graft, which should improve mucosal nutrition.'7 In either case, the graft is put into continuity with the native intestine at a second operation at a later date.
Rejection
Small bowel allografts are highly immunogenic because they contain large amounts of lymphoid material in the mesenteric lymph nodes, Peyer's patches, and lamina propria of the intestinal wall. In experimental studies in rodents, rejection has been consistendy prevented with cyclosporin monotherapy. 8 An important function of the small bowel is to act as a barrier against microbial entry to the body. The ischaemia associated with transplantation leads to a temporary loss of this barrier, therefore antibiotic prophylaxis must be given to cover the peritransplantation and early post-transplantation period. In rejection mucosal barrier function is impaired; bacteria enter the circulation and can be found in many organs.39 GVHD is also associated with damage to the mucosal barrier of the native bowel and systemic sepsis.f0 Recent work has shown that the range of bacteria within the intestine changes in both rejection and GVHD. The organisms that translocate from the bowel lumen to infect the host are not all normal enteric commensals. S epidermidis, a common cause of multisystem sepsis in sick patients in intensive care, is also commonly found in many organs during small bowel allograft rejection.' Therefore, in any rejection or GVHD episode, evidence ofsystemic infection should be sought and appropriate antibiotic treatment given immediately. Confirmation of the source of the infection can be achieved by culturing the same organisms from the stomal output or faeces of the patient. 
